Korro Bio's lead asset is expected to enter a Phase 1/2 trial in adult A1ATD patients in the second half of 2024. Analyst writes Korro's preclinical data package, particularly in the NSG PiZ mouse ...
CAMBRIDGE, Mass. & TÜBINGEN, Germany--(BUSINESS WIRE)--AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases, today emerged from ...
CAMBRIDGE, Mass. & TÜBINGEN, Germany--(BUSINESS WIRE)--AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases, today announced the ...
CHINO HILLS, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering ...
DURHAM, N.C.--(BUSINESS WIRE)-- Precision BioSciences, Inc. (DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for ...
SARANAC LAKE — Once a writer gets a story down, what comes next may be nebulous. Nicole Helget, a Minnesota-based award-winning author, teacher, Minneopa Valley Press editor-in-chief, and manuscript ...
Get any of our free daily email newsletters — news headlines, opinion, e-edition, obituaries and more. Montana State University College of Technology, Bozeman Tech Center is offering a one-day video ...
ROXBURY – Writers in the Mountains (WIM) presents Micro: The Divine Detail, a six-week editing class with Elizabeth Koster, Nov. 29 through Jan. 3, 2024. The class will be held online noon-2 p.m.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results